Detalhe da pesquisa
1.
Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis.
J Liposome Res
; 20(1): 16-23, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19530897
2.
Biodistribution study and identification of inflammation sites using 99mTc-labelled stealth pH-sensitive liposomes.
Nucl Med Commun
; 29(1): 33-8, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18049095
3.
Hydroxyapatite nanoparticles: preparation, characterization, and evaluation of their potential use in bone targeting: an animal study.
Nucl Med Commun
; 37(7): 775-82, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27076207
4.
Biodistribution study and identification of inflammatory sites using nanocapsules labeled with (99m)Tc-HMPAO.
Nucl Med Commun
; 30(9): 749-55, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19593235
5.
In vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasis.
Drug Dev Ind Pharm
; 30(3): 289-96, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15109028